Article Text

PDF

PO-1025 Persistent Wheezing Cases And Treatment With Intravenous Immunoglobulin During Infancy
  1. O Özdemir,
  2. S Bozdogan Polat
  1. Pediatric Allergy and Immunology, Sakarya University Medicine Faculty Researh and Education Hospital, Sakarya, Turkey

Abstract

Background When a physician comes across patients with recurrent wheezing are resistant to β2-agonist and anti-cholinergic therapy, known as atypical wheezing cases; he should investigate for hypogammaglobulinemia in these patients.

Aim Here, 3 cases are reported to make paediatricians aware of hypogammaglobulinemia, which is one of the reasons causing recurrent and persistent wheezing attacks during infancy and beyond.

Case presentations Case 1: 24 month-old girl presented to us with complaining of coughing and persistent wheezing. Her symptoms persisted even though she was using religiously nebulized salbutamol+budesonid therapy. Before this episode, she had 9 other wheezing attacks in her past medical history beginning from 2 months of age. Low IgG level (358 mg/dl) was detected at two different times. At the fourth day of admission, she was given IVIG 500mg/kg/dose. Case 2: 8-month-old girl came to our outpatient clinic with complaints of coughing and wheezing. Despite routine therapy, wheezing persisted for 2 months and wheezing severity increased and it did not respond to β2-agonist therapy. Low IgG level (304 mg/dl) was detected at two different times. At the 15th day of admission, she was given IVIG 500mg/kg/dose. Case 3: 20 month-old boy presented with complaints of having frequent lower respiratory tract infections. He was experiencing recurrent wheezing attacks almost every other week for the last 6 months. Low IgG level for his age (300 mg/dl) was detected twice. He was given IVIG 400 mg/kg/dose.

Conclusion In patients with persistent wheezing symptoms during infancy, especially resistant to therapy, hypogammaglobulinemi should be excluded.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.